investigator_user
investigator
user
funding
collaborators
pending
menu
bell
message
arrow_up
arrow_down
filter
layers
globe
marker
add
arrow
close
download
edit
facebook
info
linkedin
minus
plus
save
share
search
sort
twitter
remove
user-plus
user-minus
Sign Up for Updates
Map
Countries
Cancer types
All cancers but non-melanoma skin cancer
Bladder
Brain, nervous system
Breast
Cervix uteri
Colorectum
Corpus uteri
Gallbladder
Hodgkin lymphoma
Kaposi sarcoma
Kidney, renal pelvis and ureter
Larynx
Leukaemia
Lip, oral cavity
Liver and intrahepatic bile ducts
Melanoma of skin
Multiple myeloma and immunoproliferative diseases
Nasopharynx
Non-Hodgkin lymphoma
Non-Melanoma skin cancer
Oesophagus
Other pharynx
Ovary
Pancreas
Prostate
Sarcoma
Stomach
Testis
Thymus
Thyroid
Trachea, bronchus and lung
Specialities
Hematology and hematologic malignancies
Palliative Care
Pathology
Pediatric oncology or childhood cancer
Radiation Oncology
Surgery / Surgical oncology
Blog
About
Login
Project leads
Collaborators
Curative Cell-based Therapies for Chronic Lymphocytic Leukemia
Katy Rezvani
2 Collaborator(s)
Funding source
University of Texas MD Anderson Cancer Center
Follow
+ Project
+ Post
+ Event
Info
People
Posts
Katy Rezvani
University of Texas MD Anderson Cancer Center
Houston, United States
Evren Alici
Karolinska Institute
Stockholm, Sweden
Ten Feizi
Imperial College London
London, United Kingdom
Related projects
Alan Rein
Retrovirus Assembly And Maturation
Leukaemia
Hematology and hematologic malignancies
Hamid Band
Tyrosine Kinase Regulation Via Protein Degradation
Leukaemia
Hematology and hematologic malignancies
Dong-Er Zhang
Molecular Mechanism of Leukemogenesis Involving AML1-ETO
Leukaemia
Hematology and hematologic malignancies
Peter Aplan
Collaborative Pathways that Lead to Leukemia
Leukaemia
Hematology and hematologic malignancies
Jon C Aster
Oncogenic Notch Signaling
Leukaemia
Hematology and hematologic malignancies
Nora C Heisterkamp
Role of Sialic Acid Modification in ALL Survival and Drug Resistance
Leukaemia
Hematology and hematologic malignancies
Tomasz Skorski
BCR/ABL-PI-3k-ROS pathway induce genomic instability ....
Leukaemia
Hematology and hematologic malignancies
Richard A Flavell
Understanding Hemotopoietic Neoplasias using Humanized Mice
Leukaemia
Hematology and hematologic malignancies
Scott W Lowe
The impact of chromosome 17p lesions on leukemogeneis and therapy response
Leukaemia
Hematology and hematologic malignancies
